Find Oxycodone Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 124-90-3, Oxycodone hcl, Oxecta, Oxycontin, Endocodone, Roxicodone
Molecular Formula
C18H22ClNO4
Molecular Weight
351.8  g/mol
InChI Key
MUZQPDBAOYKNLO-RKXJKUSZSA-N
FDA UNII
C1ENJ2TE6C

Oxycodone Hydrochloride
A semisynthetic derivative of CODEINE.
1 2D Structure

Oxycodone Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
2.1.2 InChI
InChI=1S/C18H21NO4.ClH/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;/h3-4,13,16,21H,5-9H2,1-2H3;1H/t13-,16+,17+,18-;/m1./s1
2.1.3 InChI Key
MUZQPDBAOYKNLO-RKXJKUSZSA-N
2.1.4 Canonical SMILES
CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.Cl
2.1.5 Isomeric SMILES
CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O.Cl
2.2 Other Identifiers
2.2.1 UNII
C1ENJ2TE6C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dihydrohydroxycodeinone

2. Dihydrone

3. Dinarkon

4. Eucodal

5. Oxiconum

6. Oxycodeinon

7. Oxycodone

8. Oxycone

9. Oxycontin

10. Pancodine

11. Theocodin

2.3.2 Depositor-Supplied Synonyms

1. 124-90-3

2. Oxycodone Hcl

3. Oxecta

4. Oxycontin

5. Endocodone

6. Roxicodone

7. Oxycodone Hydrochloride Cii

8. Chebi:7859

9. 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

10. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride

11. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride

12. Roxicodone (tn)

13. Oxycontin (tn)

14. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride

15. Oxecta (tn)

16. Roxybond

17. Oxycodone Monohydrochloride

18. Schembl30095

19. Oxycodone Hydrochloride (usp)

20. Chembl1200890

21. Dtxsid80924674

22. Oxycodone Hydrochloride [mi]

23. Oxycodone Hydrochloride [usan]

24. Akos024457896

25. Oxycodone Hydrochloride [mart.]

26. Oxycodone Hydrochloride [vandf]

27. Anhydrous Oxycodone Hydrochloride

28. Oxycodone Hydrochloride [who-dd]

29. Oxycodone Hydrochloride, Analytical Standard

30. Oxycodone Hydrochloride [orange Book]

31. Oxycodone Hydrochloride Cii [usp-rs]

32. Oxycodone Hydrochloride [ep Monograph]

33. Tylox Component Oxycodone Hydrochloride

34. C08026

35. Codoxy Component Oxycodone Hydrochloride

36. D00847

37. Oxycet Component Oxycodone Hydrochloride

38. Oxycodone Hydrochloride [usp Monograph]

39. Roxicet Component Oxycodone Hydrochloride

40. Roxilox Component Oxycodone Hydrochloride

41. Troxyca Component Oxycodone Hydrochloride

42. Combunox Component Oxycodone Hydrochloride

43. Oxycodone Hydrochloride Component Of Tylox

44. Percocet Component Oxycodone Hydrochloride

45. Percodan Component Oxycodone Hydrochloride

46. Roxiprin Component Oxycodone Hydrochloride

47. Targiniq Component Oxycodone Hydrochloride

48. Xartemis Component Oxycodone Hydrochloride

49. Oxycodone Hydrochloride Component Of Codoxy

50. Oxycodone Hydrochloride Component Of Oxycet

51. Oxycodone Hydrochloride Component Of Roxicet

52. Oxycodone Hydrochloride Component Of Roxilox

53. Oxycodone Hydrochloride Component Of Troxyca

54. Oxycodone Hydrochloride Component Of Combunox

55. Oxycodone Hydrochloride Component Of Percocet

56. Oxycodone Hydrochloride Component Of Percodan

57. Oxycodone Hydrochloride Component Of Roxiprin

58. Oxycodone Hydrochloride Component Of Targiniq

59. Oxycodone Hydrochloride Component Of Xartemis

60. Percodan-demi Component Oxycodone Hydrochloride

61. Q27107601

62. Oxycodone Hydrochloride Component Of Percodan-demi

63. 14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one Hydrochloride

64. Oxycodone Hydrochloride, European Pharmacopoeia (ep) Reference Standard

65. Oxycodone Hydrochloride, United States Pharmacopeia (usp) Reference Standard

66. (5?)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

67. (5alpha,17s)-14-hydroxy-3-methoxy-17-methyl-6-oxo-4,5-epoxymorphinan-17-ium Chloride

68. 4,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

69. Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, Hydrochloride, (5.alpha.)-

70. Oxycodone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Analytical Standard, For Drug Analysis

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 351.8 g/mol
Molecular Formula C18H22ClNO4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass351.1237359 g/mol
Monoisotopic Mass351.1237359 g/mol
Topological Polar Surface Area59 Ų
Heavy Atom Count24
Formal Charge0
Complexity553
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameOxecta
Drug LabelOXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str...
Active IngredientOxycodone hydrochloride
Dosage FormTablet
RouteOral
Strength7.5mg; 5mg
Market StatusPrescription
CompanyAcura Pharms

2 of 4  
Drug NameOxycodone hydrochloride
Drug LabelDESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration...
Active IngredientOxycodone hydrochloride
Dosage FormTablet, extended release; Tablet; Capsule; Solution
Routeoral; Oral
Strength30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg
Market StatusTentative Approval; Prescription
CompanyCorepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog

3 of 4  
Drug NameOxecta
Drug LabelOXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str...
Active IngredientOxycodone hydrochloride
Dosage FormTablet
RouteOral
Strength7.5mg; 5mg
Market StatusPrescription
CompanyAcura Pharms

4 of 4  
Drug NameOxycodone hydrochloride
Drug LabelDESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration...
Active IngredientOxycodone hydrochloride
Dosage FormTablet, extended release; Tablet; Capsule; Solution
Routeoral; Oral
Strength30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg
Market StatusTentative Approval; Prescription
CompanyCorepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Analgesics, Opioid

Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)


Narcotics

Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

API SUPPLIERS

read-more
read-more

01

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF ROW, CN arrow-down AUDIT arrow-down
Veranova

02

Rusan Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rusan Pharma

03

Temad Co

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTemad- We think of world-class quality.

Flag Iran
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
Temad

04

EUROAPI

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF CN arrow-down AUDIT arrow-down
EUROAPI Compnay Banner

05

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Noramco

06

Siegfried AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSiegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.

Flag Switzerland
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner

07

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF ROW, CN arrow-down AUDIT arrow-down
Veranova

08

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF ROW, CN arrow-down AUDIT arrow-down
Veranova

09

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Noramco

10

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Noramco
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 34028

Submission : 2019-10-14

Status : Active

Type : II

Veranova

02

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32506

Submission : 2018-03-16

Status : Active

Type : II

Veranova

03

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2014-06-21

Pay. Date : 2014-06-13

DMF Number : 18472

Submission : 2005-06-30

Status : Active

Type : II

Veranova

04

Noramco Llc

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-15

Pay. Date : 2012-11-23

DMF Number : 21353

Submission : 2008-02-21

Status : Active

Type : II

Noramco

05

Noramco Llc

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2012-12-27

Pay. Date : 2012-11-23

DMF Number : 20975

Submission : 2007-10-26

Status : Active

Type : II

Noramco

06

Noramco Llc

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-16

Pay. Date : 2013-04-05

DMF Number : 16399

Submission : 2003-02-03

Status : Active

Type : II

Noramco

07

SCOPE Summit
Not Confirmed

08

Specgx Llc

Ireland

USDMF

arrow
SCOPE Summit
Not Confirmed

08

Specgx Llc

Ireland
arrow
SCOPE Summit
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-05

Pay. Date : 2012-11-27

DMF Number : 6930

Submission : 1987-04-07

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
CEP 2005-036 - Rev 04
Valid
Chemical
2024-04-10
1793
Veranova

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

Certificate Number : CEP 2005-036 - Rev 04

Status : Valid

Issue Date : 2024-04-10

Type : Chemical

Substance Number : 1793

Veranova
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content
CEP 2008-249 - Rev 04
Valid
Chemical
2025-10-20
1793
EUROAPI Compnay Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content

Certificate Number : CEP 2008-249 - Rev 04

Status : Valid

Issue Date : 2025-10-20

Type : Chemical

Substance Number : 1793

EUROAPI Compnay Banner
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
R1-CEP 2011-284 - Rev 02
Valid
Chemical
2021-02-24
1793
Noramco

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

Certificate Number : R1-CEP 2011-284 - Rev 02

Status : Valid

Issue Date : 2021-02-24

Type : Chemical

Substance Number : 1793

Noramco
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
R1-CEP 2009-058 - Rev 04
Valid
Chemical
2022-05-12
1793
Noramco

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

Certificate Number : R1-CEP 2009-058 - Rev 04

Status : Valid

Issue Date : 2022-05-12

Type : Chemical

Substance Number : 1793

Noramco
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSiegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.

Flag Switzerland
Digital Content Digital Content
R1-CEP 2006-001 - Rev 01
Valid
Chemical
2018-11-21
1793
Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSiegfried – A global CDMO delivering integrated pharmaceutical development and manufacturing solutions.

Flag Switzerland
Digital Content Digital Content

Certificate Number : R1-CEP 2006-001 - Rev 01

Status : Valid

Issue Date : 2018-11-21

Type : Chemical

Substance Number : 1793

Company Banner

06

World Health Expo
Not Confirmed
arrow
arrow
World Health Expo
Not Confirmed

Certificate Number : R0-CEP 2015-386 - Rev 00

Status : Expired

Issue Date : 2017-11-03

Type : Chemical

Substance Number : 1793

blank

07

World Health Expo
Not Confirmed
arrow
arrow
World Health Expo
Not Confirmed

Certificate Number : R1-CEP 2013-357 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2020-02-19

Type : Chemical

Substance Number : 1793

blank

08

World Health Expo
Not Confirmed
arrow
arrow
World Health Expo
Not Confirmed

Certificate Number : R1-CEP 2013-067 - Rev 00

Status : Valid

Issue Date : 2020-09-10

Type : Chemical

Substance Number : 1793

blank

09

World Health Expo
Not Confirmed
arrow
arrow
World Health Expo
Not Confirmed

Certificate Number : R1-CEP 2006-244 - Rev 04

Status : Valid

Issue Date : 2022-08-16

Type : Chemical

Substance Number : 1793

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714501800,"product":"OXYCODONE HYDROCHLORIDE BASIC DRUG \/ CONTENT 0.495 KG (*FILE NO: XVI\/4\/28\/N\/OXY\/2024)","address":"PLOT NO.58-D,GOVT. INDL.ESTATE,","city":"MUMBAI ,MAHARASHTRA","supplier":"RUSAN PHARMA LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"FSUE MOSCOW ENDOCRINE PLANT","customerCountry":"RUSSIA","quantity":"0.55","actualQuantity":"0.55","unit":"KGS","unitRateFc":"760000","totalValueFC":"5014.7","currency":"INR","unitRateINR":759999.99999999988,"date":"01-May-2024","totalValueINR":"418000","totalValueInUsd":"5014.7","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"9544425","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.58-D,GOVT. INDL.ESTATE,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719426600,"product":"REIMPORT OF OXYCODONE HYDROCHLORIDE BASIC DRUG\/CONTENT 0.495KG (BATCH NO. OCD4XO2402, OCD4XO2403) (FOC)","address":"PLOT NO.58-D,GOVT. INDL.ESTATE,","city":"MUMBAI ,MAHARASHTRA","supplier":"FSUE MOSCOW ENDOCRINE PLANT","supplierCountry":"INDIA","foreign_port":"ABU DHABI","customer":"RUSAN PHARMA LTD","customerCountry":"INDIA","quantity":"0.55","actualQuantity":"0.55","unit":"KGS","unitRateFc":"760000","totalValueFC":"5196.6","currency":"INR","unitRateINR":"788744.5","date":"27-Jun-2024","totalValueINR":"433809.5","totalValueInUsd":"5196.6","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4205234","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"ABU DHABI","supplierAddress":"NOVOHOHLOVSKAYA, 25 RUS 109052MOSCOW, RUSSIA","customerAddress":"PLOT NO.58-D,GOVT. INDL.ESTATE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728066600,"product":"OXYCODONE HYDROCHLORIDE","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"WELDING GMBH CO KG","supplierCountry":"GERMANY","foreign_port":"HAMBURG - FUHLSBUETT","customer":"MSN LABORATORIES PRIVATE LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2630","totalValueFC":"2950","currency":"EURO","unitRateINR":"247877.5","date":"05-Oct-2024","totalValueINR":"247877.5","totalValueInUsd":"2950","indian_port":"Madras Air","hs_no":"29391900","bill_no":"5964294","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"HAMBURG - FUHLSBUETT","supplierAddress":"POST BOX 3058 40 20318 HAMBURG ESPLANADE 39.20354 HAMBURG GERMANY DE","customerAddress":"MSN HOUSE, PLOT NO. C-24,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q4","strtotime":1766946600,"product":"OXYCODONE HYDROCHLORIDE USP OXYCODONE HYDROCHLORIDE USP","address":"MEDREICH HOUSE, NO12\/8,","city":"SEVA NAGAR, BANGALORE, KARNATAKA","supplier":"CHATTEM CHEMICAL A SUN PHARMA COMPANY","supplierCountry":"UNITED STATES","foreign_port":"ATLANTA, HARTSFIELD","customer":"MEDREICH LTD","customerCountry":"INDIA","quantity":"0.90","actualQuantity":"0.9","unit":"KGS","unitRateFc":"2000","totalValueFC":"1825","currency":"USD","unitRateINR":"182500","date":"29-Dec-2025","totalValueINR":"164250","totalValueInUsd":"1825","indian_port":"Bangalore Air","hs_no":"29349990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"ATLANTA, HARTSFIELD","supplierAddress":"3801 ST ELMO AVENUE CHATTANOOGA TN 37409 SDNF UNITED STATES","customerAddress":"MEDREICH HOUSE, NO12\/8,"}]
01-May-2024
29-Dec-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Oxycodone HCl is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Pain, Postoperative.


Lead Product(s): Tramadol Hydrochloride,Oxycodone Hydrochloride

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 03, 2025

blank

01

Mayo Clinic

U.S.A
arrow
World Health Expo
Not Confirmed

Mayo Clinic

U.S.A
arrow
World Health Expo
Not Confirmed

Details : Oxycodone HCl is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Pain, Postoperative.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 03, 2025

blank

Details:

Roxybond (oxycodone HCl) is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.


Lead Product(s): Oxycodone Hydrochloride,Inapplicable

Therapeutic Area: Neurology Brand Name: Roxybond

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 29, 2024

blank

02

World Health Expo
Not Confirmed
World Health Expo
Not Confirmed

Details : Roxybond (oxycodone HCl) is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Product Name : Roxybond

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 29, 2024

blank

Details:

Gabapentin Enacarbil is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Substance-Related Disorders.


Lead Product(s): Gabapentin Enacarbil,Oxycodone Hydrochloride

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 08, 2024

blank

03

World Health Expo
Not Confirmed
World Health Expo
Not Confirmed

Details : Gabapentin Enacarbil is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Substance-Related Disorders.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 08, 2024

blank
  • Development Update

Details:

Bupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Funnel Chest.


Lead Product(s): Bupivacaine,Oxycodone Hydrochloride

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: AtriCure

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 16, 2023

blank

04

Zuyderland Medisch Centrum

Country
arrow
World Health Expo
Not Confirmed

Zuyderland Medisch Centrum

Country
arrow
World Health Expo
Not Confirmed

Details : Bupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Funnel Chest.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 16, 2023

blank
  • Development Update

Details:

NYX-783 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Opioid-Related Disorders.


Lead Product(s): NYX-783,Oxycodone Hydrochloride

Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 07, 2022

blank

05

Yale University

Country
arrow
World Health Expo
Not Confirmed

Yale University

Country
arrow
World Health Expo
Not Confirmed

Details : NYX-783 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Opioid-Related Disorders.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

July 07, 2022

blank

Details:

Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain.


Lead Product(s): Oxycodone Hydrochloride,Ibuprofen

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 18, 2021

blank

06

World Health Expo
Not Confirmed
World Health Expo
Not Confirmed

Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 18, 2021

blank

Details:

Delta 9 Tetrahydrocannabinol is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cancer Pain.


Lead Product(s): Delta 9 Tetrahydrocannabinol,Cannabidiol,Oxycodone Hydrochloride

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Undisclosed

Sponsor: George Clinical | WriteSource Medical Pty Ltd

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 22, 2021

blank

07

Medlab Clinical

Australia
arrow
World Health Expo
Not Confirmed

Medlab Clinical

Australia
arrow
World Health Expo
Not Confirmed

Lead Product(s) : Delta 9 Tetrahydrocannabinol,Cannabidiol,Oxycodone Hydrochloride

Therapeutic Area : Neurology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : George Clinical | WriteSource Medical Pty Ltd

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Delta 9 Tetrahydrocannabinol is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Cancer Pain.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

March 22, 2021

blank

Details:

Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain, Postoperative.


Lead Product(s): Oxycodone Hydrochloride,Inapplicable

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 21, 2020

blank

08

World Health Expo
Not Confirmed
World Health Expo
Not Confirmed

Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain, Postoperative.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 21, 2020

blank
  • Development Update

Details:

Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Neoplasms.


Lead Product(s): Oxycodone Hydrochloride,Paracetamol

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Proteus

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 11, 2019

blank

09

SWOG Cancer Research Network

Country
arrow
World Health Expo
Not Confirmed

SWOG Cancer Research Network

Country
arrow
World Health Expo
Not Confirmed

Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Neoplasms.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 11, 2019

blank

Details:

Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Arthroplasty, Replacement, Knee.


Lead Product(s): Oxycodone Hydrochloride,Inapplicable

Therapeutic Area: Orthopedics/Orthopedic Surgery Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Ambit Biosciences | Kern Medical Center

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 19, 2019

blank

10

Mayo Clinic

U.S.A
arrow
World Health Expo
Not Confirmed

Mayo Clinic

U.S.A
arrow
World Health Expo
Not Confirmed

Lead Product(s) : Oxycodone Hydrochloride,Inapplicable

Therapeutic Area : Orthopedics/Orthopedic Surgery

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Ambit Biosciences | Kern Medical Center

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Arthroplasty, Replacement, Knee.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 19, 2019

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

Temad Co

Iran
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTemad- We think of world-class quality.

CAS Number : 115-37-7

End Use API : Oxycodone Hydrochloride

About The Company : Temad Co., established in 1997, is one of Iran's largest API producers and an innovative manufacturer of narcotic and non-narcotic products in the Middle East. ...

Temad

02

Temad Co

Iran
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTemad- We think of world-class quality.

CAS Number : 467-13-0

End Use API : Oxycodone Hydrochloride

About The Company : Temad Co., established in 1997, is one of Iran's largest API producers and an innovative manufacturer of narcotic and non-narcotic products in the Middle East. ...

Temad
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Temad Co

Iran
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTemad- We think of world-class quality.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Oxycodone

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

Temad

02

Temad Co

Iran
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTemad- We think of world-class quality.

Flag Iran
Digital Content Digital Content

Regulatory Info :

Registration Country : Iran

Paracetamol; Oxycodone Hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 325MG; 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

Temad

03

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva mg

Dosage Form : Modified Release Tablet

Dosage Strength : 10mg;5mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

04

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva mg

Dosage Form : Modified Release Tablet

Dosage Strength : 20mg;10mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

05

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva mg

Dosage Form : Modified Release Tablet

Dosage Strength : 40mg;20mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

06

Sanofi

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva

Dosage Form : Prolonged Release Tablet

Dosage Strength : 5mg;2.5mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

07

Oxycodone

Brand Name :

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 1ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

08

Oxycodone

Brand Name :

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 2ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

09

Oxycodone

Brand Name :

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 10ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

Fermion Orion Company Banner

10

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000026

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE AND ACETAMINOPHEN

Dosage Form : TABLET;ORAL

Dosage Strength : 325MG;10MG

Approval Date : 2008-10-20

Application Number : 90177

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE AND ACETAMINOPHEN

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG;7.5MG

Approval Date : 2008-10-20

Application Number : 90177

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE AND ACETAMINOPHEN

Dosage Form : TABLET;ORAL

Dosage Strength : 650MG;10MG

Approval Date : 2008-10-20

Application Number : 90177

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Approval Date : 2011-02-18

Application Number : 91313

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Approval Date : 2011-02-18

Application Number : 91313

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Approval Date : 2011-02-18

Application Number : 91313

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Approval Date : 2016-04-29

Application Number : 91313

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 20MG

Approval Date : 2016-04-29

Application Number : 91313

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

ASPIRIN; OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE AND ASPIRIN

Dosage Form : TABLET;ORAL

Dosage Strength : 325MG;4.8355MG

Approval Date : 2011-03-16

Application Number : 91670

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code :

OXYCODONE HYDROCHLORIDE

Brand Name : OXYCODONE HYDROCHLORIDE

Dosage Form : CAPSULE;ORAL

Dosage Strength : 5MG

Approval Date : 2012-07-26

Application Number : 203107

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Dr Reddy Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Helvepharm Ag

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva mg

Dosage Form : Modified Release Tablet

Dosage Strength : 10mg;5mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

02

Helvepharm Ag

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva mg

Dosage Form : Modified Release Tablet

Dosage Strength : 20mg;10mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

03

Helvepharm Ag

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva mg

Dosage Form : Modified Release Tablet

Dosage Strength : 40mg;20mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

04

Helvepharm Ag

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Oxycodone Hydrochloride; Naloxone Hydrochloride Anhydrous

Brand Name : Oxycodone Naloxone Zentiva

Dosage Form : Prolonged Release Tablet

Dosage Strength : 5mg;2.5mg

Packaging :

Approval Date : 18/08/2023

Application Number : 69126

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

05

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000026

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner

06

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000040

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner

07

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000057

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner

08

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000019

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner

09

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 60mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000071

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner

10

Oxycodone Hydrochloride

Brand Name : Oxycodone Depot Orion

Dosage Form : Tablet

Dosage Strength : 80mg

Packaging :

Approval Date : 16/12/2013

Application Number : 20120830000088

Regulatory Info : Approved

Registration Country : Sweden

Fermion Orion Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 5MG

USFDA APPLICATION NUMBER - 200534

read-more

DOSAGE - SOLUTION;ORAL - 100MG/5ML

USFDA APPLICATION NUMBER - 200535

read-more

DOSAGE - SOLUTION;ORAL - 5MG/5ML

USFDA APPLICATION NUMBER - 200535

read-more

DOSAGE - SOLUTION;ORAL - 5MG/5ML **Federal Re...DOSAGE - SOLUTION;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 201194

read-more

DOSAGE - TABLET;ORAL - 5MG

USFDA APPLICATION NUMBER - 202080

read-more

DOSAGE - TABLET;ORAL - 7.5MG

USFDA APPLICATION NUMBER - 202080

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 325M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 204031

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 13....DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 18M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 18MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 27M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 27MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 36M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 36MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 9MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 10MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 15MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 20MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 30MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 40MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 60MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 80MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET;ORAL - 325MG;5MG **Federal Re...DOSAGE - TABLET;ORAL - 325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 87003

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

read-more
read-more

01

Brand Name : Oxycontin Franchise

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Oxycontin Franchise

Japan
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 60

2018 Revenue in Millions : 70

Growth (%) : -15

blank

02

Brand Name : Percocet

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Percocet

Ireland
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 110

2019 Revenue in Millions : 116

Growth (%) : -5

blank

03

Brand Name : Oxycodone (API) and Oxycodone-containing Tablets

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Oxycodone (API) and Oxycodone-containing Tablets

Ireland
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 68

2019 Revenue in Millions : 75

Growth (%) : -9

blank

04

Brand Name : Oxycontin Franchise

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Oxycontin Franchise

Japan
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 50

2019 Revenue in Millions : 61

Growth (%) : -17

blank

05

Brand Name : Oxycontin Franchise

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Oxycontin Franchise

Japan
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 42

2020 Revenue in Millions : 48

Growth (%) : -6

blank

06

Brand Name : Oxycodone (API) and Oxycodone-containing Tablets

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Oxycodone (API) and Oxycodone-containing Tablets

Ireland
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 69

2020 Revenue in Millions : 68

Growth (%) : 0

blank

07

Brand Name : Percocet

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Percocet

Ireland
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 104

2020 Revenue in Millions : 110

Growth (%) : -6

blank

08

Brand Name : Percocet

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Percocet

Ireland
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 104

2021 Revenue in Millions : 104

Growth (%) : 0

blank

09

Brand Name : Percocet

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Percocet

Ireland
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 106

2022 Revenue in Millions : 104

Growth (%) : 2

blank

10

Brand Name : Oxycontin Franchise

Oxycodone

arrow
Vitafoods India
Not Confirmed

Brand Name : Oxycontin Franchise

Japan
arrow
Vitafoods India
Not Confirmed

Oxycodone

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 35

2021 Revenue in Millions : 42

Growth (%) : -18

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 124-90-3 / Oxycodone Hydrochloride API manufacturers, exporters & distributors?

Oxycodone Hydrochloride manufacturers, exporters & distributors 1

89

PharmaCompass offers a list of Oxycodone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxycodone Hydrochloride manufacturer or Oxycodone Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxycodone Hydrochloride manufacturer or Oxycodone Hydrochloride supplier.

PharmaCompass also assists you with knowing the Oxycodone Hydrochloride API Price utilized in the formulation of products. Oxycodone Hydrochloride API Price is not always fixed or binding as the Oxycodone Hydrochloride Price is obtained through a variety of data sources. The Oxycodone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Oxycodone Hydrochloride

Synonyms

124-90-3, Oxycodone hcl, Oxecta, Oxycontin, Endocodone, Roxicodone

Cas Number

124-90-3

Unique Ingredient Identifier (UNII)

C1ENJ2TE6C

About Oxycodone Hydrochloride

A semisynthetic derivative of CODEINE.

Oxycodone Manufacturers

A Oxycodone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxycodone, including repackagers and relabelers. The FDA regulates Oxycodone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxycodone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Oxycodone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Oxycodone Suppliers

A Oxycodone supplier is an individual or a company that provides Oxycodone active pharmaceutical ingredient (API) or Oxycodone finished formulations upon request. The Oxycodone suppliers may include Oxycodone API manufacturers, exporters, distributors and traders.

click here to find a list of Oxycodone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Oxycodone USDMF

A Oxycodone DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxycodone active pharmaceutical ingredient (API) in detail. Different forms of Oxycodone DMFs exist exist since differing nations have different regulations, such as Oxycodone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Oxycodone DMF submitted to regulatory agencies in the US is known as a USDMF. Oxycodone USDMF includes data on Oxycodone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxycodone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Oxycodone suppliers with USDMF on PharmaCompass.

Oxycodone JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Oxycodone Drug Master File in Japan (Oxycodone JDMF) empowers Oxycodone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Oxycodone JDMF during the approval evaluation for pharmaceutical products. At the time of Oxycodone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Oxycodone suppliers with JDMF on PharmaCompass.

Oxycodone KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Oxycodone Drug Master File in Korea (Oxycodone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxycodone. The MFDS reviews the Oxycodone KDMF as part of the drug registration process and uses the information provided in the Oxycodone KDMF to evaluate the safety and efficacy of the drug.

After submitting a Oxycodone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxycodone API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Oxycodone suppliers with KDMF on PharmaCompass.

Oxycodone CEP

A Oxycodone CEP of the European Pharmacopoeia monograph is often referred to as a Oxycodone Certificate of Suitability (COS). The purpose of a Oxycodone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxycodone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxycodone to their clients by showing that a Oxycodone CEP has been issued for it. The manufacturer submits a Oxycodone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxycodone CEP holder for the record. Additionally, the data presented in the Oxycodone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxycodone DMF.

A Oxycodone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxycodone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Oxycodone suppliers with CEP (COS) on PharmaCompass.

Oxycodone WC

A Oxycodone written confirmation (Oxycodone WC) is an official document issued by a regulatory agency to a Oxycodone manufacturer, verifying that the manufacturing facility of a Oxycodone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxycodone APIs or Oxycodone finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxycodone WC (written confirmation) as part of the regulatory process.

click here to find a list of Oxycodone suppliers with Written Confirmation (WC) on PharmaCompass.

Oxycodone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxycodone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Oxycodone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Oxycodone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Oxycodone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxycodone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Oxycodone suppliers with NDC on PharmaCompass.

Oxycodone GMP

Oxycodone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Oxycodone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxycodone GMP manufacturer or Oxycodone GMP API supplier for your needs.

Oxycodone CoA

A Oxycodone CoA (Certificate of Analysis) is a formal document that attests to Oxycodone's compliance with Oxycodone specifications and serves as a tool for batch-level quality control.

Oxycodone CoA mostly includes findings from lab analyses of a specific batch. For each Oxycodone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Oxycodone may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxycodone EP), Oxycodone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxycodone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty